SSYS vs YB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Stratasys exhibits severe operational weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating fundamentals. While the company maintains a strong balance sheet with very low debt (D/E 0.03) and high liquidity (Current Ratio 3.57), it is failing to translate this stability into profitability or growth. Revenue is contracting (-6.90% YoY) and the stock is in a long-term bearish trend, losing over 58% of its value over five years. The current valuation below book value (P/B 0.90) suggests a value play, but the lack of earnings growth makes it a likely value trap.
YB exhibits a stable financial profile with a Piotroski F-Score of 6/9 and an exceptionally clean balance sheet featuring zero debt. The stock is severely undervalued, trading at $17.35, which is significantly below both its Graham Number ($31.22) and its growth-based Intrinsic Value ($118.59). While technical trends are currently bearish and insider sentiment is weak, the combination of a 4.32 P/E ratio, 96% gross margins, and 30%+ growth rates presents a compelling deep-value opportunity.
Compare Another Pair
Related Comparisons
SSYS vs YB: Head-to-Head Comparison
This page compares Stratasys Ltd. (SSYS) and Yuanbao Inc. (YB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.